Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Prestige Consumer Healthcare Reaffirms FY24 Revenue Outlook Of $1.135B-$1.14B Vs. Consensus Of $1.03B, With EPS Of $4.27-$4.32 Vs. Consensus Of $3.92

Author: Benzinga Newsdesk | August 03, 2023 06:29am

Posted In: PBH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist